tiprankstipranks
Advertisement
Advertisement

NRXP Stock Latest News

Psychedelic: Enveric, Helus, Bright Minds report earnings results
The FlyPsychedelic: Enveric, Helus, Bright Minds report earnings results
4d ago
LLY
ATAI
Nrx Pharmaceuticals Earnings Call Signals Cautious Momentum
PremiumCompany Announcements
Nrx Pharmaceuticals Earnings Call Signals Cautious Momentum
5d ago
NRXP
Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study
PremiumThe Fly
Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study
7d ago
LLY
ATAI
NRXP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NRXP Earnings this Week: How Will it Perform?
9d ago
NRXP
NRx Advances FDA Review of Ketamine ANDA Packaging Issue
PremiumCompany Announcements
NRx Advances FDA Review of Ketamine ANDA Packaging Issue
17d ago
8K
NRXP
FDA completes review of NRx Pharmaceuticals preservative-free ketamine ANDA
PremiumThe FlyFDA completes review of NRx Pharmaceuticals preservative-free ketamine ANDA
17d ago
NRXP
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
Premium
The Fly
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
1M ago
LLY
ATAI
NRx Defense Systems Advances DARPA-Backed Depression Trial
Premium
Company Announcements
NRx Defense Systems Advances DARPA-Backed Depression Trial
1M ago
8K
NRXP
NRx Pharmaceuticals issues response to Kadima statements
PremiumThe Fly
NRx Pharmaceuticals issues response to Kadima statements
2M ago
NRXP
Psychedelic: Definium soars on study results for LSD-based depression treatment
PremiumThe Fly
Psychedelic: Definium soars on study results for LSD-based depression treatment
2M ago
ATAI
CMND
Kadima Neuropsychiatry Institute alleges NRx breached contract
PremiumThe Fly
Kadima Neuropsychiatry Institute alleges NRx breached contract
2M ago
NRXP
ZETA announces treatment of first patient with Zeta TMS Navigation System
PremiumThe Fly
ZETA announces treatment of first patient with Zeta TMS Navigation System
2M ago
NRXP
Thomas Shrader Reiterates Buy on NRXP, Maintains $25 Price Target on NRX-100/101 FDA and RWE-Driven Upside
PremiumRatingsThomas Shrader Reiterates Buy on NRXP, Maintains $25 Price Target on NRX-100/101 FDA and RWE-Driven Upside
2M ago
NRXP
NRx Pharmaceuticals announces FDA grant of expanded access protocol for NRX-101
Premium
The Fly
NRx Pharmaceuticals announces FDA grant of expanded access protocol for NRX-101
2M ago
NRXP
Psychedelic: Optimi Health completes psilocybin export to the UK
Premium
The Fly
Psychedelic: Optimi Health completes psilocybin export to the UK
2M ago
IXHL
MIRA
NRx Pharmaceuticals Announces $20 Million Public Stock Offering
PremiumCompany Announcements
NRx Pharmaceuticals Announces $20 Million Public Stock Offering
3M ago
8K
NRXP
NRx Pharmaceuticals 5.7M share Spot Secondary priced at $3.50
PremiumThe Fly
NRx Pharmaceuticals 5.7M share Spot Secondary priced at $3.50
3M ago
NRXP
NRx Pharmaceuticals Plans Underwritten Public Stock Offering
PremiumCompany Announcements
NRx Pharmaceuticals Plans Underwritten Public Stock Offering
3M ago
8K
NRXP
NRx Pharmaceuticals announces common stock offering, no amount given
PremiumThe Fly
NRx Pharmaceuticals announces common stock offering, no amount given
3M ago
NRXP
Psychedelic: Optimi Health advances natural psilocybin extract
PremiumThe FlyPsychedelic: Optimi Health advances natural psilocybin extract
3M ago
CMND
CMPS
NRX Pharmaceuticals: Regulatory and Commercial De-Risking Supports Unchanged $45 Price Target and Buy Rating
Premium
Ratings
NRX Pharmaceuticals: Regulatory and Commercial De-Risking Supports Unchanged $45 Price Target and Buy Rating
3M ago
NRXP
NRx Pharmaceuticals Earnings Call Maps 2026 Catalyst Path
Premium
Company Announcements
NRx Pharmaceuticals Earnings Call Maps 2026 Catalyst Path
3M ago
NRXP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >